tradingkey.logo
tradingkey.logo
Search

Italfarmaco Says European Commission Approves Duvyzat For Duchenne Muscular Dystrophy Treatment

ReutersJun 6, 2025 3:21 PM
facebooktwitterlinkedin

- Italfarmaco SpA:

  • EUROPEAN COMMISSION APPROVES DUVYZAT FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI